Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response

PURPOSE: Even though pazopanib, a multitargeted tyrosine kinase inhibitor, has been approved for refractory soft tissue sarcoma (STS), little is known about the molecular determinants of the response to pazopanib. We performed integrative molecular characterization to identify potential predictors o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Jung Yong, Cho, Hee Jin, Yun, Kum-Hee, Lee, Young Han, Kim, Seung Hyun, Baek, Wooyeol, Kim, Sang Kyum, Lee, Yurimi, Choi, Yoon-La, Kwon, Minsuk, Kim, Hyo Song, Lee, Jeeyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101793/
https://www.ncbi.nlm.nih.gov/pubmed/36164943
http://dx.doi.org/10.4143/crt.2022.251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101793/
https://www.ncbi.nlm.nih.gov/pubmed/36164943
http://dx.doi.org/10.4143/crt.2022.251

Ejemplares similares